Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

View the 50 largest pharmaceutical companies in the world listings here

Sino Biopharmaceutical in the Drug Discovery & Development Pharma 50

Sino Biopharmaceutical

Rank: 44

2021 Rank: 41

Hong Kong, China
www.sinobiopharm.com

2021 Revenues ($USD) : $4,164,034,848
2021 Revenues (foreign currencies) : RMB26,861,356,000
2021 R&D spend : $570,046,971
2021 Number of Employees : 25,579
Fiscal Year End : 12/31/2021
Leader : CEO Li Yi

Sino Biopharm

[Image courtesy of Sino Biopharm]

Sino Biopharm is a research-driven pharmaceutical conglomerate based in mainland China. The company markets various biopharmaceutical and chemical medicines for treating tumors, liver diseases, orthopedic diseases, infections, respiratory system diseases and more. The core business in the group is the ChiaTai Tianqing Pharmaceutical Group. Sino Biopharm also developes modernized Chinese medicine as well as biopharma products. The company was founded in 2000. —BB

Tell Us What You Think! Cancel reply

You must be logged in to post a comment.

Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE